CDH1 and cancer: These promising results indicate that the AI-based model can robustly classify ILCs and uncover CDH1 inactivating mechanisms, paving the way for the development of diagnostic AI models applied to pathology that facilitate accurate cancer diagnosis and biologic discoveries.